NDC 69043-063 - Ketamine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69043-063
- Package NDCs from labels
- 69043-063-01
- Manufacturer
- Cronus Pharma LLC
- Effective date
- 2026-03-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Ketamine Hydrochloride Injection - Cronus Pharma LLC | Cronus Pharma LLC | 2026-03-10 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69043-063-01 | Ketamine Hydrochloride | 1 in 1 CARTON | INJECTION | 1 | 2 | |
| 69043-063-01 | Ketamine Hydrochloride | 10 mL in 1 VIAL, GLASS | INJECTION | 10 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| KETAMINE HYDROCHLORIDE | KETAMINE HYDROCHLORIDE | Henry Schein, Inc. | 76d6aad3-0515-49da-a6e1-3fe2a1938a24 | 2026-09-08 | Warnings, Adverse reactions | 238083 O18YUO0I83 |
| Ketamine Hydrochloride | KETAMINE HYDROCHLORIDE | Civica, Inc. | 58c86d9b-8694-4bd8-8254-f19ee3ad60b0 | 2026-06-09 | Warnings, Adverse reactions | 238083 O18YUO0I83 |
| Ketamine Hydrochloride | KETAMINE HYDROCHLORIDE | Hospira, Inc. | bb912318-2e22-4469-b0a2-774803ee1bb8 | 2026-05-12 | Warnings, Adverse reactions | 238083 O18YUO0I83 |
| Ketamine Hydrochloride | KETAMINE HYDROCHLORIDE | Gland Pharma Limited | b96a0a23-3ca0-4a92-bd8b-1e9921931772 | 2026-04-16 | Warnings, Adverse reactions | 238083 O18YUO0I83 |
| Ketalar | KETAMINE HYDROCHLORIDE | Par Health USA, LLC | 14e8f864-8b8a-4e7e-8439-e510d3107063 | 2026-03-27 | Warnings, Adverse reactions | 238083 O18YUO0I83 |
| ketamine hydrochloride | KETAMINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | ac2e715d-251c-4e3f-b91c-972f466d0beb | 2025-10-03 | Warnings, Adverse reactions | 238083 O18YUO0I83 |
| KETAMINE HYDROCHLORIDE | KETAMINE HYDROCHLORIDE | Baxter Healthcare Corporation | 549d6ed3-3c9b-4ea2-8aaf-f61d43e04602 | 2025-06-26 | Warnings, Adverse reactions | O18YUO0I83 |
| ketamine hydrochloride | KETAMINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | cc67b0fd-ca73-49f6-b5ca-705dc7331776 | 2025-04-23 | Warnings, Adverse reactions | 238083 O18YUO0I83 |
| KETALAR | KETAMINE HYDROCHLORIDE | Henry Schein, Inc | 46dab560-8ecd-4d92-8c92-6baa2310b09b | 2025-01-27 | Warnings, Adverse reactions | O18YUO0I83 |
| Ketamine Hydrochloride | KETAMINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 58487c78-a641-4278-acc0-343596ee8683 | 2024-02-26 | Warnings, Adverse reactions | 238083 O18YUO0I83 |
| Ketamine Hydrochloride | KETAMINE HYDROCHLORIDE | Sagent Pharmaceuticals | 902c3785-a3cb-472b-ac15-394ac646271d | 2023-05-01 | Warnings, Adverse reactions | 238083 O18YUO0I83 |
| Ketamine Hydrochloride | KETAMINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | c8e90cec-621e-f8d8-e053-2a95a90a49d4 | 2023-04-27 | Warnings, Adverse reactions | 238083 O18YUO0I83 |
| Ketamine Hydrochloride | KETAMINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | ea600f8a-857f-4e0e-e053-2995a90a017d | 2023-04-24 | Warnings, Adverse reactions | 238083 O18YUO0I83 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.